Expression of matrix metalloproteinases and their inhibitors in human brain tumors

Clinical and Experimental Metastasis

Volumn 17, Issue 7, 1999, Pages 555-566

  Kachra, Zarin ^d   Beaulieu, Edith ^d   Delbecchi, Louis ^d   Mousseau, Nathalie ^d   Berthelet, France ^a   Moumdjian, Robert ^d   Del Maestro, Rolando ^b   Béliveau, Richard ^c  

^a NOTRE DAME HOSPITAL   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d NONE

Author keywords

Matrix metalloproteinase; Tumor angiegenesis; Tumor invasion

Indexed keywords

ENZYME PRECURSOR; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; BRAIN LEVEL; BRAIN METASTASIS; CANCER GRADING; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ASSAY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MENINGIOMA; NEURILEMOMA; OLIGODENDROGLIOMA; PROTEIN EXPRESSION;

ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; GELATIN; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MENINGEAL NEOPLASMS; MENINGIOMA; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEURILEMMOMA; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR MARKERS, BIOLOGICAL;

EID: 0038527822     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006760632766     Document Type: Article

References (50)

1. 1. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T et al. Microvessel density in brain tumors. Anticancer Res 1997; 17: 4747-54.
2. 2. Mignatti P, Rifkin DB. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 1996; 49: 117-37.
3. 3. Stetler-Stevenson WG, Corcoran ML. Tumor angiogenesis: Functional similarities with tumor invasion. In Goldberg ID and Rosen EM (ed): Regulation of Angiogenesis. Basel, Switzerland: Birkhaüser 1997; 413-8.
4. 4. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993; 7: 1434-41.
5. 5. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteinases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994; 7: 2062-72.
6. 6. Powell WC, Matrisian LM. Complex roles of matrix metalloproteinases intumor progression. Curr Top Microbiol Immunol 1996; 213: 1-21.
7. 7. Mohanam S, Wang SW, Rayford A et al. Expression of tissue inhibitors of metalloproteinases: Negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis 1995; 13: 57-62.
8. 8. Nuovo GJ, MacConnell PB, Simsir A et al. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 1995; 55: 267-75.
9. 9. Sugiura Y, Shimada H, Seeger RC et al. Matrix metalloproteinases -2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis. Cancer Res 1998; 58: 2209-16.
10. 10. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Dis 1996; 2: 70-6.
11. 11. Pei D. Identification and characterization of the fifth membrane-type matrixmetalloproteinase MT5-MMP. J Biol Chem 1999; 274: 8925-32.
12. 12. Bartlett JD, Simmer JP, Xue J et al. Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene 1996; 183: 123-8.
13. 13. Cossins J, Dudgeon TJ, Catlin G et al. Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Commun 1996; 228: 494-8.
14. 14. Stolow MA, Bauzon DD, Li J et al. dentification and characterization of a novel collagenase in Xenopus laevis: Possible roles during frog development. Mol Biol Cell 1996; 7: 1471-83.
15. 15. Llano E, Pendas AM, Knäuper V et al. Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 1997; 36: 15101-8.
16. 16. Pendas AM, Knäuper V, Puente XS et al. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 1997; 272: 4281-6.
17. 17. Yang M, Murray MT, Kurkinen M. A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development. J Biol Chem 1997; 272: 13527-33.
18. 18. Corcoran ML, Hewitt RE, Kleiner DE Jr, Stetler-Stevenson WG. MMP-2: Expression, activation and inhibition. Enzyme Protein 1996; 49: 7-19.
19. 19. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE. Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc Natl Acad Sci USA 1990; 87: 364-8.
20. 20. Greene J, Wang M, Liu YE et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271: 30375-80.
21. 21. Goldberg GI, Strongin A, Collier IE et al. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267: 4583-91.
22. 22. Strongin AY, Collier I, Bannikov G et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270: 5331-8.
23. 23. Khokha R, Zimmer MJ, Wilson SM, Chambers AF. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 1992; 10: 365-70.
24. 24. Murphy AN, Unsworth EJ, Stetler-Slevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993; 157: 351-8.
25. 25. Johnson MD, Kim HR, Chesler L et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994; 160: 194-202.
26. 26. Imren S, Kohn DB, Shimada H et al. Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res 1996; 56: 2891-5.
27. 27. Watanabe M, Takahashi Y, Ohta T et al. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer 1996; 77: 1676-80.
28. 28. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metaloproteinases-2 (TIMP-2). J Cell Sci 1994; 107: 2373-9.
29. 29. Corcoran ML, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J Biol Chem 1995; 270: 13453-9.
30. 30. Sato H, Takino T, Okada Y, Cao J et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-5.
31. 31. Imai K, Ohuchi E, Aoki T et al. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 1996; 56: 2707-10.
32. 32. Butler GS, Butler MJ, Atkinson SJ et al. The TIMP2 membrane type I metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 1998; 273: 871-80.
33. 33. Rooprai HK, McCormick D. Proteases and their inhibitors in human brain tumors: A review. Anticancer Res 1997; 17: 4151-62.
34. 34. Nakagawa T, Kubota T, Kabuto M et al. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994; 81: 69-77.
35. 35. Rooprai HK, Van Meter T, Rucklidge GJ et al. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int J Oncol 1998; 13: 1153-7.
36. 36. Rao JS, Steck PA, Mohanam S et al. Elevated levels of M(r) 92000 type IV collagenase in human brain tumors. Cancer Res 1993; 53: 2208-11.
37. 37. Zülch KJ. Principles of the new World Health Organization (WHO) classification of brain tumors. Neuroradiology 1980; 19: 59-66.
38. 38. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
39. 39. Fridman R, Toth M, Pena D, Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 1995; 55: 2548-55.
40. 40. Colton CA, Keri JE, Chen WT, Monsky WL. Protease production by cultured microglia: Substrate gel analysis and immobilized matrix degradation. J Neurosci Res 1993; 35: 297-304.
41. 41. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 1994; 218: 325-9.
42. 42. Matsumoto S, Koayashi T, Katoh M et al. Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: Relationship to lesion development. Am J Pathol 1998; 153: 109-19.
43. 43. Curci JA, Lio S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrixmetalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998; 102: 1900-10.
44. 44. Wagner S, Stegen C, Bouterfa H et al. Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10. J Neurooncol 1998; 40: 113-22.
45. 45. Forsyth PA, Wong H, Laing TD et al. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 1999; 79: 1828-35.
46. 46. Lampert K, Machein U, Machein MR et al. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Path 1998; 153: 429-39.
47. 47. Del Maestro RF. Angiogenesis. In Berger M, Wilson C (eds): The Gliomas. Philadelphia, Pennsylvania: W.B. Saunders, 1998; 87-106.
48. 48. Schmidt NO, Westphal M, Hagel C et al. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 1999; 84: 10-8.
49. 49. Plat KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995; 15: 339-47.
50. 50. Zhang H, Kelly G, Zerrilo C et al. Expression of a cleaved Brain-specific extracellular matrix protein mediates glioma cell invasion in vivo. J Neurosci 1998; 18: 2370-6.